Corcept is leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). To date, we have discovered more than 1,000 selective proprietary cortisol modulators.
In 2012, we received FDA approval of Korlym® (mifepristone), the first approved treatment for hypercortisolism (Cushing’s syndrome).
Today, our team and collaborators continue to unlock the possibilities of cortisol modulation as a way to treat serious diseases. With more than 30 ongoing studies across a wide range of disease areas, including endocrinology, oncology, metabolism, and neurology, we remain dedicated to advancing the possibilities of cortisol modulation.
What began as a ripple of scientific truth is now poised to unleash a sea change of discovery representing a fundamental shift in the way we understand and treat disease.
The Associate Director, Pipeline and Portfolio Market Planning is accountable for developing product strategies, including indication selection and sequencing, global market and disease understanding, competitive landscape assessments, patient journey and treatment paradigms, target product profiles (TPPs), product differentiation, positioning and value proposition, forecasting and market access/pricing dynamics for select pipeline programs. The therapeutic area scope will initially focus on oncology with increasing responsibilities across other therapeutic areas.
Responsibilities:
- Lead program-level strategy projects and initiatives in support of maximizing portfolio value
- Synthesize data from various sources including primary market research, secondary data, and analytics into actionable insights
- Provide physician, patient, and payer perspective into clinical strategy and planning
- Develop & maintain long-range revenue forecasts and valuations for new programs
- Develop competitive intelligence tracking tools and analysis to support programs
- Work cross-functionally with Commercial teams and Development organization to support integrated planning activities
- Create and manage target product profiles (TPPs) for pipeline products, working with development team to influence and support clinical development decisions
- Manage ad hoc strategic projects across portfolio
- Conduct asset assessments and due diligence for business development opportunities
Preferred Skills, Qualifications and Technical Proficiencies:
- Ability to master new therapeutic areas across multiple perspectives including scientific, clinical, commercial, and regulatory
- Solid understanding of market research principles
- Ability to develop and deliver compelling presentations to senior management
- Ability to rapidly synthesize information from multiple sources, communicate ideas and data both verbally and written in a persuasive manner
- Ability to lead across a matrixed organization and to integrate cross-functional thinking into a clear strategy
- Strong understanding of the drug development process for early through late-stage programs
- Occasional travel required for corporate and industry events
Preferred Education and Experience:
- Bachelor's degree required. Advanced degree preferred (MBA, MSc, PhD, PharmD)
- 5+ years in product planning preferred, with relevant professional experience in new product planning, market planning, corporate development and/or healthcare strategy consulting considered
- Industry experience within oncology required
- Experience on a cross-functional drug development team preferred
The pay range that the Company reasonably expects to pay for this headquarters-based position is $204,500 - $240,600; the pay ultimately offered may vary based on legitimate considerations, including geographic location, job-related knowledge, skills, experience, and education.
Applicants must be currently authorized to work in the United States on a full-time basis.
For information on how Corcept collects, uses, discloses, protects, and otherwise processes personal information and an explanation of the rights and choices available to you with respect to your personal information, please refer to our Privacy Notice link.
Corcept appreciates the commitment and hard work of all our team members as we strive to discover and develop novel treatments for patients with serious unmet medical needs.
Please visit our website at: https://www.corcept.com/
Corcept is an Equal Opportunity Employer
Corcept will not conduct interviews via text message or messaging platforms and will not ask you to download anything as part of your interview. Though we use third-party tools to help with advertising our jobs, please be vigilant in checking that the communication is in fact coming from Corcept.
What We Do
Leading the field in the discovery of drugs that modulate the effects of cortisol.
The adverse effects of excess cortisol have been Corcept’s focus since the company’s inception. Abnormal levels and release of cortisol play a role in a variety of metabolic, oncological, and psychiatric diseases, and we are currently studying a new generation of compounds that may mitigate the effects of excess cortisol.
